HUTCHMED (HCM) Competitors $15.68 +0.27 (+1.75%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM vs. MRNA, BPMC, VRNA, BBIO, ROIV, RVMD, ELAN, LEGN, GRFS, and TLXShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Moderna (MRNA), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), BridgeBio Pharma (BBIO), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Elanco Animal Health (ELAN), Legend Biotech (LEGN), Grifols (GRFS), and Telix Pharmaceuticals (TLX). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Its Competitors Moderna Blueprint Medicines Verona Pharma PLC American Depositary Share BridgeBio Pharma Roivant Sciences Revolution Medicines Elanco Animal Health Legend Biotech Grifols Telix Pharmaceuticals HUTCHMED (NASDAQ:HCM) and Moderna (NASDAQ:MRNA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation. Do analysts prefer HCM or MRNA? HUTCHMED presently has a consensus price target of $19.00, indicating a potential upside of 21.17%. Moderna has a consensus price target of $46.61, indicating a potential upside of 53.96%. Given Moderna's stronger consensus rating and higher probable upside, analysts clearly believe Moderna is more favorable than HUTCHMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Moderna 4 Sell rating(s) 15 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.04 Which has more risk and volatility, HCM or MRNA? HUTCHMED has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Moderna has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Which has higher valuation and earnings, HCM or MRNA? HUTCHMED has higher earnings, but lower revenue than Moderna. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHUTCHMED$630.20M4.34$37.73MN/AN/AModerna$3.24B3.62-$3.56B-$8.73-3.47 Do institutionals and insiders have more ownership in HCM or MRNA? 8.8% of HUTCHMED shares are held by institutional investors. Comparatively, 75.3% of Moderna shares are held by institutional investors. 3.6% of HUTCHMED shares are held by company insiders. Comparatively, 11.0% of Moderna shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer HCM or MRNA? In the previous week, Moderna had 15 more articles in the media than HUTCHMED. MarketBeat recorded 21 mentions for Moderna and 6 mentions for HUTCHMED. HUTCHMED's average media sentiment score of 0.22 beat Moderna's score of 0.22 indicating that HUTCHMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Moderna 10 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Neutral Is HCM or MRNA more profitable? HUTCHMED has a net margin of 0.00% compared to Moderna's net margin of -105.67%. HUTCHMED's return on equity of 0.00% beat Moderna's return on equity.Company Net Margins Return on Equity Return on Assets HUTCHMEDN/A N/A N/A Moderna -105.67%-28.69%-21.94% SummaryModerna beats HUTCHMED on 9 of the 15 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.74B$2.90B$5.50B$8.93BDividend YieldN/A2.69%5.38%4.12%P/E RatioN/A21.2826.2519.86Price / Sales4.34280.14415.14113.78Price / Cash52.4041.8936.4957.06Price / Book3.547.468.055.38Net Income$37.73M-$55.05M$3.16B$248.50M7 Day Performance1.29%2.25%1.78%2.78%1 Month Performance15.29%7.17%4.74%5.84%1 Year Performance-8.94%5.13%35.81%20.06% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED1.7684 of 5 stars$15.68+1.8%$19.00+21.2%-12.2%$2.74B$630.20M0.001,811MRNAModerna4.3556 of 5 stars$25.67-0.9%$46.61+81.6%-75.3%$10.02B$3.24B-2.945,800Trending NewsOptions VolumeGap UpBPMCBlueprint Medicines1.5411 of 5 stars$128.40+0.2%$128.06-0.3%+17.5%$8.28B$508.82M-51.98640High Trading VolumeVRNAVerona Pharma PLC American Depositary Share2.556 of 5 stars$97.05+2.9%$101.10+4.2%+483.4%$8.03B$42.28M-48.5330Positive NewsAnalyst ForecastBBIOBridgeBio Pharma4.7079 of 5 stars$42.17+1.1%$56.67+34.4%+69.8%$7.92B$221.90M-11.95400Analyst ForecastInsider TradeROIVRoivant Sciences1.9285 of 5 stars$11.50+0.4%$17.50+52.2%+1.0%$7.78B$29.05M-46.00860RVMDRevolution Medicines4.4912 of 5 stars$40.04+1.0%$67.08+67.5%-4.9%$7.39B$11.58M-10.01250Analyst RevisionELANElanco Animal Health2.3219 of 5 stars$13.36-0.7%$15.17+13.5%+2.5%$6.68B$4.44B18.059,000LEGNLegend Biotech2.4528 of 5 stars$33.85-0.4%$76.20+125.1%-21.1%$6.25B$627.24M-57.372,609Positive NewsGRFSGrifols4.1197 of 5 stars$8.37-4.6%$10.30+23.1%+43.3%$6.03B$7.81B7.1523,822Analyst DowngradeTLXTelix PharmaceuticalsN/A$16.39-4.4%$22.00+34.2%N/A$5.80B$516.72M0.00N/AGap DownHigh Trading Volume Related Companies and Tools Related Companies MRNA Alternatives BPMC Alternatives VRNA Alternatives BBIO Alternatives ROIV Alternatives RVMD Alternatives ELAN Alternatives LEGN Alternatives GRFS Alternatives TLX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCM) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCM Stock Alerts